Showing results (51-60 of 76) with videos related to

Sort By:
Pageof 8
Cancer|October 21, 2023
Genomic ancestry in kidney cancer: Correlations with clinical and molecular featuresRitesh R Kotecha, Andrea Knezevic, Kanika Arora, et al.
Urologic Oncology|December 22, 2023
Surgical outcomes of cytoreductive nephrectomy in patients receiving systemic immunotherapy for advanced renal cell carcinomaStephen W Reese, Lennert Eismann, Charlie White, et al.
European Urology Oncology|November 9, 2023
A Phase 2 Trial of Talazoparib and Avelumab in Genomically Defined Metastatic Kidney CancerRitesh R Kotecha, Sahil D Doshi, Andrea Knezevic, et al.
Medrxiv : the Preprint Server for Health Sciences|May 2, 2025
Pathologic Response to Immunotherapy is Associated with Survival in Patients Undergoing Delayed Nephrectomy for Metastatic Renal Cell CarcinomaYash S Khandwala, Stephen W Reese, Burcin A Ucpinar, et al.
ESMO Open|June 6, 2025
Real-world clinical outcomes of sacituzumab govitecan after prior exposure to enfortumab vedotin in patients with metastatic urothelial carcinomaM Sternschuss, N Toumbacaris, J P Das, et al.
European Urology Oncology|November 27, 2025
Pathologic Response to Immunotherapy Is Associated with Survival in Patients Undergoing Delayed Nephrectomy for Metastatic Renal Cell CarcinomaYash S Khandwala, Stephen W Reese, Burcin A Ucpinar, et al.
European Urology Focus|March 15, 2022
Genomic and Metabolic Hallmarks of SDH- and FH-deficient Renal Cell CarcinomasAngela Yoo, Cerise Tang, Mark Zucker, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 29, 2025
Phase I Dose Escalation Trial Combining Olaparib and Thoracic Radiation Therapy in Extensive-Stage Small Cell Lung CancerAndreas Rimner, Benjamin H Lok, Daphna Y Gelblum, et al.
European Urology Oncology|March 30, 2025
A Phase 1b/2 Study of Talazoparib and Axitinib in Patients with Advanced Clear-cell Renal Cell CarcinomaRitesh R Kotecha, Sahil D Doshi, Andrea Knezevic, et al.
Cell Metabolism|July 6, 2023
Immunometabolic coevolution defines unique microenvironmental niches in ccRCCCerise Tang, Amy X Xie, Eric Minwei Liu, et al.
Pageof 8